GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool
All Semaglutide Brands India
Generic SemaglutideType 2 Diabetes
MSN Laboratories logo

SemabestGeneric semaglutide for type 2 diabetes in India 2026

by MSN Laboratories · ₹3,990/month · DCGI approved April 2026

Active ingredient
Semaglutide (GLP-1 receptor agonist)
Indication
Type 2 Diabetes
Manufacturer
MSN Laboratories Pvt Ltd
DCGI status
Approved April 2026
Price (MRP)
₹3,990/month
Roughly 50% below the innovator (Ozempic) at equivalent dose. Backward-integrated India manufacturing — both API and pen device made in India.
Format
Prefilled pen
India-manufactured pen device complying with global regulatory standards
Prescription
Schedule H — required

How Semabest compares

Semabest is MSN Laboratories' brand of generic semaglutide for type 2 diabetes — positioned as the first integrated made-in-India semaglutide with backward integration across both USDMF-grade API and the pen device itself. The April 2026 launch followed a Phase III bioequivalence study with comparable HbA1c, fasting glucose, post-prandial glucose, and weight-loss outcomes to the reference (innovator) product.

About MSN Laboratories

MSN Laboratories is a Hyderabad-headquartered pharmaceutical company with a strong India and emerging-market franchise in oncology, cardiometabolic, and antiviral therapy. The Semabest launch — first integrated India-manufactured semaglutide — reflects MSN's vertical-integration strategy: in-house API + in-house pen device production reduces dependence on imported components and stabilises supply at scale.

Who is Semabest for?

Semabest is approved in India for type 2 diabetes mellitus in adults. Typically used as add-on therapy when metformin + lifestyle aren't achieving glycaemic targets, or as first-line in T2D patients with established cardiovascular disease, obesity, or chronic kidney disease per RSSDI 2024 guidelines.

Not sure if you qualify? Take the 5-minute Indian-guideline eligibility check →

Semabest for specific conditions

Semabest for type 2 diabetes →Semabest and prediabetes →

Semabest cost in India

MRP for Semabest: ₹3,990/month. Actual pharmacy pricing varies by city, pharmacy, and channel. Online prescription pharmacies typically offer modest discounts off MRP with cold-chain delivery; hospital pharmacy pricing is usually at MRP.

Compare with all India brands: GLP-1 therapy cost in India 2026 →

Compared to other GLP-1 brands in India

Semabest is an Indian generic semaglutide. Same active molecule as Ozempic and Wegovy (Novo Nordisk innovator brands), with clinical efficacy that follows the molecule rather than the brand. Other Indian generics include Sundae, Noveltreat, Obeda, Semaglyn, Sembolic, and Samakind — all at similar price points.

All GLP-1 comparisons →All Indian semaglutide brands →Clinical evidence library →GLP-1 blog (India) →

Semabest — frequently asked questions

Is Semabest available in India? Is it DCGI-approved?+
Yes — Semabest is DCGI-approved and currently available across India. The drug received DCGI approval in April 2026 for type 2 diabetes, manufactured by MSN Laboratories Pvt Ltd. It is distributed through licensed retail and online prescription pharmacies and hospital pharmacies across Indian metros and most tier-2 cities. Semabest is a Schedule H drug — a doctor's prescription is required. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
What does Semabest cost in India in 2026?+
Semabest is priced at ₹3,990/month (Roughly 50% below the innovator (Ozempic) at equivalent dose. Backward-integrated India manufacturing — both API and pen device made in India.). Actual pharmacy pricing may vary by city and channel. For brand-by-brand price comparisons across all India brands, see our cost guide. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
Do I need a prescription to buy Semabest?+
Yes — Semabest is a Schedule H drug in India and can only be dispensed against a valid prescription from a registered medical practitioner. Any legitimate online prescription pharmacy will require you to upload your prescription before order fulfillment.
Who is Semabest for?+
Semabest is approved for type 2 diabetes in India. Indian guideline eligibility typically requires BMI ≥27.5 (obesity indication) or HbA1c above target on first-line therapy (T2D indication), often with comorbidities at BMI ≥25. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
How does Semabest compare to Ozempic and Wegovy?+
Semabest contains the same active molecule (semaglutide) as Ozempic and Wegovy. Clinical efficacy is comparable; the difference is brand, manufacturer support, pen design, and price. Semabest (₹3,990/month) is meaningfully cheaper than Ozempic (₹5,660+/month) or Wegovy (up to ₹16,400/month) — useful for cost-sensitive patients on long-term therapy.
Where can I buy Semabest in India?+
Semabest is a Schedule H drug — available through licensed retail and online prescription pharmacies and hospital pharmacies across India with a doctor's prescription. Always buy from a licensed pharmacy to avoid counterfeit products; never use sources that dispense without verifying a prescription. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.

Source

BioSpectrum India — MSN Labs Semabest launch

GLP-1 Check is informational, not a medical diagnosis. Semaglutide is a Schedule H drug in India and requires a prescription from a registered medical practitioner. Always consult a qualified physician before starting any treatment.

Are you eligible for Semabest?

Take the free 5-minute triage to check your GLP-1 readiness against Indian clinical guidelines.

Check My Eligibility →

Looking at other brands?

See full price comparison across all 25+ DCGI-approved brands →